
Telvisart AM 40mg/5mg Tablet
Marketer
Apotheca Pharmaceuticals Private Limited
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg)
Overview Telvisart AM 40mg/5mg Tablet
Amlodipine/Telmisartan 40mg/5mg tablets combine two blood pressure-lowering agents. This medication eases blood vessel constriction, improving blood flow and reducing strain on the heart, thus lowering the risk of stroke or heart attack. This medication can be taken with or without food, but consistent daily use at the same time, as directed by your physician, is crucial. Dosage is personalized. Continued use, even if feeling well, is vital for ongoing blood pressure control and risk reduction. Discontinue only under medical guidance. Lifestyle modifications, including regular exercise, smoking cessation, and a low-sodium, low-fat diet, enhance its effectiveness. Common side effects may include ankle/foot swelling, headache, drowsiness, dizziness, fatigue, and indigestion. Avoid driving or activities requiring alertness until its effects are known. Report persistent or bothersome side effects to your doctor. Prior to use, inform your doctor of any kidney or liver issues, severe dehydration, pregnancy, or breastfeeding. Regular blood pressure monitoring and potential kidney function tests are necessary while taking this medication.
Uses of Telvisart AM 40mg/5mg Tablet
Managing Elevated Blood Pressure
Major Benefits of Telvisart AM 40mg/5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 40mg/5mg Telvisart AM Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent daily timing is recommended.
Common Side effects of Telvisart AM 40mg/5mg Tablet:
- Sleepiness
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Upset stomach
- Peripheral edema
- Sudden decrease in blood pressure
How to use Telvisart AM 40mg/5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The 40mg/5mg Telvisart AM Tablet should be swallowed whole; avoid crushing, chewing, or breaking it. While it can be ingested with or without food, consistent daily timing is recommended.
How Telvisart AM 40mg/5mg Tablet works:
Each Telvisart AM 40mg/5mg tablet unites Telmisartan, an angiotensin receptor blocker (ARB), with Amlodipine, a calcium channel blocker (CCB). This dual action promotes vasodilation and enhances cardiac output, resulting in a significant reduction of blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Telvisart AM 40mg/5mg tablets is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telvisart AM 40mg/5mg tablets during pregnancy poses a confirmed risk to the fetus. While generally unsafe, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Telvisart AM 40mg/5mg tablets safely. A small amount of research in humans indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by Telvisart AM 40mg/5mg Tablet, a medication that can induce side effects such as dizziness, headaches, nausea, or fatigue. These effects can compromise concentration and safe driving.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Telvisart AM 40mg/5mg tablets without requiring a dosage alteration.
LiverCAUTION
Patients with hepatic impairment should use Telvisart AM 40mg/5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telvisart AM 40mg/5mg Tablet :
Should you forget a Telvisart AM 40mg/5mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telvisart AM 40mg/5mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Heart-related |
